Finally, FoxO1 inhibition and large-dose Ang IV had no synergistic effect on diabetic cardiomyopathy, but FoxO1 inhibition completely reversed the detrimental effects of divalinal administration. Here, FOXO1 is linked to diabetic cardiomyopathy.